Research ArticleOriginal Article
Open Access

Validity and reliability of the Arabic version of topical corticosteroid phobia (TOPICOP©) questionnaire

Hashem M. Al-Dujaily, Huda A. Hussein, Bahaa Abdelrahim, Mohammad Shawer, Ahmad Mehyar, Baha’ Aljeradat, Dima Batarseh, Sarah Khraim, Amjad Abdeen and Noor Almaani
Saudi Medical Journal March 2025, 46 (3) 307-315; DOI: https://doi.org/10.15537/smj.2025.46.3.20240506

References

  1. 1.↵
    1. Nutten S
    . Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 2015; 66: 8-16.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Lopez Carrera YI,
    2. Al Hammadi A,
    3. Huang YH,
    4. Llamado LJ,
    5. Mahgoub E,
    6. Tallman AM
    . Epidemiology, diagnosis, and treatment of atopic dermatitis in the developing countries of Asia, Africa, Latin America, and the Middle East: a review. Dermatol Ther (Heidelb) 2019; 9: 685-705.
    OpenUrlPubMed
  3. 3.↵
    1. Mahmoud O,
    2. Yosipovitch G,
    3. Attia E
    . Burden of disease and unmet needs in the diagnosis and management of atopic dermatitis in the Arabic population of the Middle East. J Clin Med 2023; 12: 4675.
    OpenUrlPubMed
  4. 4.↵
    1. Chu DK,
    2. Schneider L,
    3. Asiniwasis RN,
    4. Boguniewicz M,
    5. De Benedetto A,
    6. Ellison K, et al.
    Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol 2024; 132: 274-312.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Contento M,
    2. Cline A,
    3. Russo M
    . Steroid phobia: a review of prevalence, risk factors, and interventions. Am J Clin Dermatol 2021; 22: 837-851.
    OpenUrlPubMed
  6. 6.↵
    1. Saito-Abe M,
    2. Futamura M,
    3. Yamamoto-Hanada K,
    4. Yang L,
    5. Suzuki K,
    6. Ohya Y
    . Topical corticosteroid phobia among caretakers of children with atopic dermatitis: a cross-sectional study using TOPICOP in Japan. Pediatr Dermatol 2019; 36: 311-316.
    OpenUrlPubMed
  7. 7.↵
    1. Albogami MF,
    2. AlJomaie MS,
    3. Almarri SS,
    4. Al-Malki S,
    5. Tamur S,
    6. Aljaid M, et al.
    Topical corticosteroid phobia among parents of children with atopic dermatitis (eczema)- a cross-sectional study. Patient Prefer Adherence 2023; 17: 2761-2772.
    OpenUrlPubMed
  8. 8.↵
    1. Alamri RA,
    2. Al Satti HS
    . Knowledge and attitudes towards topical corticosteroids among previous users in the general population of Saudi Arabia. Cureus 2024; 16: e55373.
    OpenUrlPubMed
  9. 9.↵
    1. Lee JY,
    2. Her Y,
    3. Kim CW,
    4. Kim SS
    . Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol 2015; 27: 499-506.
    OpenUrlPubMed
  10. 10.↵
    1. Kojima R,
    2. Fujiwara T,
    3. Matsuda A,
    4. Narita M,
    5. Matsubara O,
    6. Nonoyama S, et al.
    Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol 2013; 30: 29-35.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Alzolibani AA
    . Impact of atopic dermatitis on the quality of life of Saudi children. Saudi Med J 2014; 35: 391-396.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Gonzales F,
    2. Ramdane N,
    3. Delebarre-Sauvage C,
    4. Modiano P,
    5. Duhamel A,
    6. Lasek A
    . Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP® scale: prevalence, risk factors and the impact of therapeutic patient education. J Eur Acad Dermatol Venereol 2017; 31: e172-e174.
    OpenUrlPubMed
  13. 13.↵
    1. Moret L,
    2. Anthoine E,
    3. Aubert-Wastiaux H,
    4. Le Rhun A,
    5. Leux C,
    6. Mazereeuw-Hautier J, et al.
    TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One 2013; 8: e76493.
    OpenUrlPubMed
  14. 14.↵
    1. Stalder JF,
    2. Aubert H,
    3. Anthoine E,
    4. Futamura M,
    5. Marcoux D,
    6. Morren MA, et al.
    Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score. Allergy 2017; 72: 1713-1719.
    OpenUrlPubMed
  15. 15.↵
    1. Koster ES,
    2. Philbert D,
    3. Zheng X,
    4. Moradi N,
    5. de Vries TW,
    6. Bouvy ML
    . Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis. Int J Clin Pharm 2021; 43: 1237-1244.
    OpenUrlPubMed
  16. 16.↵
    1. Futamura M,
    2. Yamamoto-Hanada K,
    3. Saito M,
    4. Batchelor J,
    5. Nakahara M,
    6. Nakahara T, et al.
    [The Japanese version of TOPICOP scale among patients with atopic dermatitis: a translation and feasibility study]. Arerugi 2016; 65: 66-72. [In Japanese].
    OpenUrlPubMed
  17. 17.↵
    1. Boonpuen N,
    2. Srimuang A,
    3. Puangpet P,
    4. Supsrisunjai C
    . Validity and reliability of the topical corticosteroid phobia (TOPICOP©) questionnaire: Thai version. SMJ 2023; 75: 115-120.
    OpenUrl
  18. 18.↵
    1. Tsang S,
    2. Royse CF,
    3. Terkawi AS
    . Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth 2017; 11: S80-S89.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Yusoff MSB
    . ABC of content validation and content validity index calculation. EIMJ 2019; 11: 49-54.
    OpenUrl
  20. 20.↵
    1. Alsukait SF,
    2. Alshamlan NM,
    3. Alhalees ZZ,
    4. Alsuwaidan SN,
    5. Alajlan AM
    . Topical corticosteroids knowledge, attitudes, and practices of primary care physicians. Saudi Med J 2017; 38: 662-665.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Barakat M,
    2. Thiab S,
    3. Farha RA,
    4. Alshweiki AO,
    5. Thaher R,
    6. Alsughaier A, et al.
    An evaluation of pharmacists’ general attitudes, knowledge, and phobias regarding medications that include corticosteroids: a cross-sectional study. J Pharm Health Care Sci 2024; 10: 8.
    OpenUrlPubMed
  22. 22.↵
    1. Yin LJ,
    2. Wei TK,
    3. Choi E,
    4. Chandran NS
    . TOPICOP© scale for steroid phobia - difficulties and suggestions for application in clinical research. J Dermatolog Treat 2020; 31: 624-625.
    OpenUrlPubMed
  23. 23.↵
    1. Gunawan J,
    2. Marzilli C,
    3. Aungsuroch Y
    . Establishing appropriate sample size for developing and validating a questionnaire in nursing research. Belitung Nurs J 2021; 7: 356-360.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords